healthCMI

Photopheresis is a form of apheresis and photodynamic therapy in which blood is treated with photosensitizing agents and irradiated with specific wavelengths of light. It is also known as extracorporeal photopheresis (ECP). ECP is leukapheresis based therapeutic procedure approved by the U.S. Food and Drug Administration for treatment of advance cutaneous T-cell lymphoma. Additionally, ECP is used in treating disorders like graft versus host disease (GVHD), atopic dermatitis, scleroderma, lichen planus, lupus erythematosus, Crohn’s disease, type 1 diabetes. Many photopheresis products like open and closed systems are available in the market, of which, only closed system is approved by the U.S. FDA, because of its lower risk of contamination and infection during reinfusion. Furthermore, closed systems are technologically advanced systems in comparison to open systems. Photopheresis Products Market Drivers Rise in prevalence of autoimmune diseases and increase in...

Photopheresis is a form of apheresis and photodynamic therapy in which blood is treated with photosensitizing agents and irradiated with specific wavelengths of light. It is also known as extracorporeal photopheresis (ECP). ECP is leukapheresis based therapeutic procedure approved by the U.S. Food and Drug Administration for treatment of advance cutaneous T-cell lymphoma. Additionally, ECP is used in treating disorders like graft versus host disease (GVHD), atopic dermatitis, scleroderma, lichen planus, lupus erythematosus, Crohn’s disease, type 1 diabetes. Many photopheresis products like open and closed systems are available in the market, of which, only closed system is approved by the U.S. FDA, because of its lower risk of contamination and infection during reinfusion. Furthermore, closed systems are technologically advanced systems in comparison to open systems. Photopheresis Products Market Drivers Rise in prevalence of autoimmune diseases and increase in...